Author:
Taher Ali,El-Beshlawy Amal,Elalfy Mohsen S.,Al Zir Kusai,Daar Shahina,Habr Dany,Kriemler-Krahn Ulrike,Hmissi Abdel,Al Jefri Abdullah
Subject
Hematology,General Medicine
Reference20 articles.
1. Results of long-term iron-chelating therapy;Gabutti;Acta Haematol,1996
2. Survival in β-thalassaemia major in the UK: data from the UK Thalassaemia Register;Modell;Lancet,2000
3. Iron-chelating therapy and the treatment of thalassemia;Olivieri;Blood,1997
4. Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload;Piga;Haematologica,2006
5. Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in paediatric patients with β-thalassaemia major;Galanello;Haematologica,2006
Cited by
126 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献